Seeking Alpha
搜索文档
DGRO's Growth Is Better Valued Than VYM's Yield
Seeking Alpha· 2025-12-17 05:16
Join for a 100% Risk-Free trial and see if our proven method can help you too. You do not need to pay for the costly lessons from the market itself.Sensor Unlimited is an economist by training with a PhD, with a focus on financial economics. She is a quantitative modeler and for the past decade she has been covering the mortgage market, commercial market, and the banking industry. She writes about asset allocation and ETFs, particularly those related to the overall market, bonds, banking and financial secto ...
Alector Stock Down After Latozinemab Failure, Eyes On Phase 2 Catalyst (ALEC)
Seeking Alpha· 2025-12-17 05:10
Alector Inc. ( ALEC ) stock has had quite a volatile year. We saw great momentum from the company as it progressed with Latozinemab through the pipeline. However, in late October, we saw a less-than-positive data readout, which droppedI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me ...
Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms (NASDAQ:AUPH)
Seeking Alpha· 2025-12-17 04:57
Aurinia Pharmaceuticals Inc. ( AUPH ) has had an exciting few months, with an earnings update showing continued Lupkynis growth, a competitor's drug being approved for lupus nephritis, and a request for information from the FDA. I rated AUPH aScientist and trader of biotech stock. Focus on trading around events such as trial results and NDA/BLA approvals. Also covering companies in industries regulated by the FDA. Articles present my opinion on stocks, but don't constitute investment advice.Analyst’s Disclo ...
Kyverna Therapeutics: "Strong Buy" Rating As Positive SPS Data Leads To 1st Half 2026 BLA Filing
Seeking Alpha· 2025-12-17 04:46
This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...
Mitsui Chemicals, Inc. (MITUY) Discusses Plant Accident Response, Organizational Changes, and Business Outlook - Slideshow (OTCMKTS:MITUY) 2025-12-16
Seeking Alpha· 2025-12-17 04:39
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
QLD: A 2x Nasdaq-100 Leveraged ETF Built For Bull Runs (NYSEARCA:QLD)
Seeking Alpha· 2025-12-17 04:38
The ProShares Ultra QQQ ETF ( QLD ) is a leveraged ETF that can be used to improve portfolio performance in positive momentum trends through tactical entries and with a relatively short horizon (3-6 months), while closely monitoring the macro narrativeAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not rece ...
Banco De Chile: New Government And Better Economic Outlook Make Me Bullish (NYSE:BCH)
Seeking Alpha· 2025-12-17 04:38
If you enjoyed this, consider Ian's Insider Corner to enjoy access to similar initiation reports for all the new stocks that we buy. Membership also includes an active chat room, weekly updates, and my responses to your questions.My general argument was that Chile was likely to move from its current socialist government, headed by President Gabriel Boric, toward a more pro-business direction. HereIan Bezek is a former hedge fund analyst at Kerrisdale Capital. He has spent the decade living in Latin America, ...
QLD: A 2x Nasdaq-100 Leveraged ETF Built For Bull Runs
Seeking Alpha· 2025-12-17 04:38
The ProShares Ultra QQQ ETF ( QLD ) is a leveraged ETF that can be used to improve portfolio performance in positive momentum trends through tactical entries and with a relatively short horizon (3-6 months), while closely monitoring the macro narrativeAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not rece ...
Banco De Chile: New Government And Better Economic Outlook Make Me Bullish
Seeking Alpha· 2025-12-17 04:38
If you enjoyed this, consider Ian's Insider Corner to enjoy access to similar initiation reports for all the new stocks that we buy. Membership also includes an active chat room, weekly updates, and my responses to your questions.My general argument was that Chile was likely to move from its current socialist government, headed by President Gabriel Boric, toward a more pro-business direction. HereIan Bezek is a former hedge fund analyst at Kerrisdale Capital. He has spent the decade living in Latin America, ...
American Airlines: A Clear Case For A Buy Led By Multiple Expansion (AAL)
Seeking Alpha· 2025-12-17 04:34
American Airlines Group Inc. ( AAL ) has proactively worked towards debt reduction, bringing it down to ~36 billion Q3 2025 compared to ~46 billion in 2021. Although still at a relatively high level, it intends to further reduce to betterI have successfully cleared CFA Level 3 and possess strong analytical skills, coupled with a deep curiosity to understand the complexities of businesses across diverse industries. This combination perfectly aligns with my passion for equity research. I take great interest i ...